Melioidosis Vaccine Symposium: Moving from animal models to man

26 February 2019, Oxford, UK

Twenty-five scientists from 12 institutes across five countries joined Prof Susie Dunachie for this highly successful workshop discussing the roadmap to first-in-human melioidosis vaccine clinical trials and the lessons learned in the TB field when moving vaccine candidates from animals to humans.

VALIDATE members can access the workshop slides and video on our Resources portal.

Description of the workshop

VALIDATE and Prof Susie Dunachie hosted a Melioidosis Vaccine Symposium entitled “Moving from animal models to man” on the afternoon of Tuesday 26 February 2019 at the University of Oxford, UK. The workshop discussed the roadmap to first-in-human melioidosis vaccine clinical trials and the lessons learned in the TB field when moving vaccine candidates from animals to humans. The workshop was open to all VALIDATE members who found it useful and relevant to their work.

Agenda

12:30: Networking lunch

13:30: Introduction – Prof Helen Fletcher, LSHTM, Co-Director of VALIDATE

13:45: The prospect of a melioidosis vaccine – Prof Susie Dunachie, University of Oxford

14:15: Lessons from the TB vaccine pipeline and immune monitoring – Prof Helen Fletcher

14:45: The DTRA funding portfolio for Burkholderia – Dr Julie Boylan, DTRA. The presentation was confidential, so slides and video are not available for this talk.

15:15: Coffee

15:30: Candidates and next steps – Assoc Prof Paul Brett, University of Nevada

16:45: Concluding remarks